Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03407963 | Feasibility of Prostatic Arterial Embolization in Low-risk Patients With Unilateral Prostate Cancer Under Active Surveillance: Monocentric Pilot Study(CAPEMBOL) | completed | N/A | 10 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06007586 | Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients | completed | Phase 3 | 143 | Sichuan Cancer Hospital and Research InstituteOTHER |
| 1 |
| Dec 4, 2025 |
| clinicaltrials |
| NCT06768086 | Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy(PREHYSMYOM) | completed | — | 90 | Centro di Ricerca Clinica SalentinoNETWORK | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06870539 | Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment | completed | — | 49 | Mayo ClinicOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT03249142 | Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer(INeOV) | completed | Phase 1 / Phase 2 | 69 | ARCAGY/ GINECO GROUPOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT02326064 | Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4(TORCH) | completed | — | 221 | Centre Hospitalier Departemental VendeeOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT04447703 | Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study | completed | N/A | 346 | Thomas Jefferson UniversityOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT04543903 | Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer | completed | N/A | 1 | Alpha Tau Medical LTD.INDUSTRY | 1 | Dec 2, 2025 | clinicaltrials |
| NCT03284684 | Kinetics of Perioperative Circulating DNA in Cancer Surgery(Periop ctDNA) | completed | — | 30 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT06128525 | Prostate Resection After Microwave Ablation (PRAMA) | completed | N/A | 1 | University of Southern CaliforniaOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT07250841 | Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women | completed | — | 984 | Kasr El Aini HospitalOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT05795595 | A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 19 | CRISPR Therapeutics AGINDUSTRY | 1 | Nov 26, 2025 | clinicaltrials |
| NCT01147965 | QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA | completed | Phase 1 / Phase 2 | 43 | NantCell, Inc.INDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT01961843 | Abiraterone Acetate for Castrate Resistant Prostate Cancer | completed | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT05445167 | A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain | completed | Phase 3 | 89 | Kissei Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT00957411 | Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer(CETUXICOL) | completed | Phase 2 | 76 | Institut CurieOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07210918 | Serum Trace Element Levels in Some Gynecological Diseases | completed | N/A | 40 | Cumhuriyet UniversityOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05255393 | Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer | completed | — | 111 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT00853710 | Test Semiquantitative Prostate Specific Antigen (PSA) | completed | N/A | 94 | Institut CurieOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT02050542 | Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.(MURIELLE) | completed | N/A | 108 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT04702633 | Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer(PROSTA-PAP) | completed | — | 127 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT05472532 | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)(INOVOLINE) | completed | N/A | 101 | Hospices Civils de LyonOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06534008 | Strive Cardio for Endometrial Cancer Survivors | completed | N/A | 33 | Jess S. GorzelitzOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT05383482 | Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 | completed | Phase 1 / Phase 2 | 22 | Laekna LimitedINDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT06925113 | A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan(HERGYN) | completed | — | 509 | Daiichi SankyoINDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT03839524 | A Trial Evaluating TG4050 in Ovarian Carcinoma. | completed | Phase 1 | 64 | TransgeneINDUSTRY | 2 | Nov 14, 2025 | clinicaltrials |
| NCT03738228 | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Nov 12, 2025 | clinicaltrials |
| NCT04272086 | Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy | completed | Phase 4 | 140 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT05220501 | Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI(OPTIMUM) | completed | N/A | 804 | Sunnybrook Health Sciences CentreOTHER | 8 | Nov 10, 2025 | clinicaltrials |
| NCT01676818 | Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer | completed | Phase 2 | 32 | University of Southern CaliforniaOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT03734653 | Testosterone Therapy in Castration Resistant Prostate Cancer | completed | Early Phase 1 | 30 | University of Colorado, DenverOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT05978232 | NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients | completed | N/A | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT03860961 | Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy | completed | N/A | 550 | NRG OncologyOTHER | 1 | Nov 3, 2025 | clinicaltrials |
| NCT02111941 | Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Early Phase 1 | 19 | Mayo ClinicOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT05311527 | UroLift System With SAbR for Prostate Cancer and BPH | completed | N/A | 15 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT06250751 | Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca(BETR-PC) | completed | N/A | 27 | Virginia Commonwealth UniversityOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT03480646 | ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 175 | Constellation PharmaceuticalsINDUSTRY | 1 | Oct 29, 2025 | clinicaltrials |
| NCT02203695 | Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy | completed | Phase 2 | 86 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 28, 2025 | clinicaltrials |
| NCT06861504 | The Femscope Calm Collect Device | completed | N/A | 13 | University of MichiganOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT02294461 | An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants | completed | Phase 3 | 395 | Astellas Pharma IncINDUSTRY | 4 | Oct 24, 2025 | clinicaltrials |
| NCT07220499 | Whole Food Plant-based Diet to Improve Outcomes in Prostate Cancer | completed | N/A | 11 | Pacific Cancer CareOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT03325634 | Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer | completed | Phase 1 | 15 | University of Colorado, DenverOTHER | 1 | Oct 23, 2025 | clinicaltrials |
| NCT02159989 | Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 83 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2025 | clinicaltrials |
| NCT04049227 | Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer | completed | Early Phase 1 | 27 | Northwestern UniversityOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT04386993 | De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer(DeCRESCEndo) | completed | N/A | 25 | Washington University School of MedicineOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT04838613 | Study of Diagnostic Performance of [18F]CTT1057 in BCR(GuidePath) | completed | Phase 3 | 190 | Novartis PharmaceuticalsINDUSTRY | 4 | Oct 20, 2025 | clinicaltrials |
| NCT02141438 | Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer(REASSURE) | completed | — | 1,472 | BayerINDUSTRY | 20 | Oct 16, 2025 | clinicaltrials |
| NCT03507608 | Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression | completed | Early Phase 1 | 25 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 16, 2025 | clinicaltrials |
| NCT05247853 | HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV | completed | — | 3,127 | Montefiore Medical CenterOTHER | 1 | Oct 16, 2025 | clinicaltrials |
| NCT03580499 | Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy | completed | N/A | 43 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Dec 4, 2025source: clinicaltrials